Results 161 to 170 of about 17,221 (177)

A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia or immunosenescence

Multiple Sclerosis Journal, 2019
Martin Diebold, Valerian L Altersberger, Bernhard F Décard   +2 more
exaly  

Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps

Therapeutic Advances in Drug Safety, 2012
Joseph R Berger
exaly  

Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence

Multiple Sclerosis Journal, 2017
Renaud Du Pasquier
exaly  

Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients

Multiple Sclerosis Journal, 2019
Yasuo Oshima, Tetsuya Tanimoto, Koichiro Yuji   +2 more
exaly  

Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab “infusion group”

Multiple Sclerosis Journal, 2013
Bernhard Hemmer
exaly  

Progressive multifocal leukoencephalopathy

2020
Eric M. L. Williamson, Joseph R. Berger
openaire   +1 more source

Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare

Journal of NeuroVirology, 1995
exaly  

Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA’s adverse event reporting system

Expert Opinion on Drug Safety, 2016
Cheng Chen, Charles L Bennett
exaly  

Characterization of the VP1 loop mutations widespread among JC polyomavirus isolates associated with progressive multifocal leukoencephalopathy

Biochemical and Biophysical Research Communications, 2005
Hiroshi Ikegaya
exaly  

Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies

Cancer Control, 2017
exaly